Evidence for Two Distinct G-protein-coupled ADP Receptors Mediating Platelet Activation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Thrombosis and Haemostasis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0037-1614427PMID 10348701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Basis for ADP-induced Platelet Activation

  1998influential reference
• Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.

  1998cited by this paper
• ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.

  1998cited by this paper
• The regulation of vascular function by P2 receptors: multiple sites and multiple receptors.

  1998cited by this paper
• Identification of a P2X1 purinoceptor expressed on human platelets.

  1998cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptors

  1998cited by this paper
• The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.

  1998cited by this paper
• Role of P2Y1 purinoceptor in ADP‐induced platelet activation

  1998cited by this paper
• Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C

  1997cited by this paper
• Defective platelet activation in Gαq-deficient mice

  1997cited by this paper
• Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel

  1997cited by this paper
• The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells

  1997cited by this paper
• The Wellcome Prize Lecture. Calcium entry mechanisms in human platelets

  1997cited by this paper
• Nucleotide receptors.

  1997cited by this paper
• ADP-induced platelet activation.

  1997cited by this paper
• Towards a revised nomenclature for P1 and P2 receptors.

  1997cited by this paper
• Defective platelet activation in G alpha(q)-deficient mice.

  1997cited by this paper
• Activation of ADP Receptors and Platelet Function

  1997cited by this paper
• Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines

  1997cited by this paper
• ADP Receptors on Platelets

  1996influential reference
• ADP receptors on platelets and ADP-selective antiaggregating agents.

  1996cited by this paper
• Second messenger cascade specificity and pharmacological selectivity of the human P2Y1‐purinoceptor

  1996cited by this paper
• Activation of Receptor-operated Cation Channels via P Not P Purinoceptors in Human Platelets (*)

  1996cited by this paper
• Identification of competitive antagonists of the P2Y1 receptor.

  1996cited by this paper
• cAMP is not an important messenger for ADP-induced platelet aggregation.

  1996cited by this paper
• An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.

  1995cited by this paper
• The human platelet ADP receptor activates Gi2 proteins.

  1995cited by this paper
• P2-purinergic receptors: subtype-associated signaling responses and structure.

  1995cited by this paper
• A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

  1995cited by this paper
• Receptors for ADP on human blood platelets.

  1994cited by this paper
• Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.

  1992cited by this paper
• ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes.

  1992cited by this paper
• Identification of a nucleotide-binding site on glycoprotein IIb. Relationship to ADP-induced platelet activation.

  1991cited by this paper
• Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies.

  1990cited by this paper
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper
• SPECIFIC BUT NONCOMPETITIVE INHIBITION BY 2‐ALKYLTHIO ANALOGUES OF ADENOSINE 5′‐MONOPHOSPHATE AND ADENOSINE 5′‐TRIPHOSPHATE OF HUMAN PLATELET AGGREGATION INDUCED BY ADENOSINE 5′‐DIPHOSPHATE

  1982cited by this paper
• 2-Methylthioadenosine-5′-phosphate: a Specific Inhibitor of Platelet Aggregation

  1969cited by this paper

• Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets.

  2024cites this paper
• The Platelet P2 Receptors

  2019cites this paper
• The relationship between the metabolites of the dietary flavonoid quercetin, and haemostasis and thrombosis : an integrated systems approach

  2018cites this paper
• Impaired activation of murine platelets lacking

  2018cites this paper
• Exploration biologique des thrombopathies constitutionnelles - déficit en CalDAG-GEFI : un exemple de recherche translationnelle

  2017cites this paper
• Current and novel P2Y12 ADP receptor antagonists and bleeding risk in dental surgery

  2016cites this paper
• Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways

  2015cites this paper
• P2Y receptors in Alzheimer's disease

  2015cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• Impact of Cigarette Smoking on P2Y12 Receptor Binding Activity Before and After Clopidogrel Therapy in Patients with Coronary Artery Disease

  2014cites this paper
• Platelet Aggregometry and Aspects of Residual Platelet Reactivity in Patients with Coronary Artery Disease Treated with Aspirin and Clopidogrel

  2013cites this paper
• Хемилюминесценция тромбоцитов. Использование метода хемилюминесценции для определения активности тромбоцитов

  2013cites this paper
• Activation of Phosphoinositide 3-Kinase Aggregation Induced by the PAR1-Activating Peptide Through the Late A Key Role of Adenosine Diphosphate in the Irreversible Platelet

  2013cites this paper
• and ADP receptors 3 β IIb α human platelets requires coordinated signaling through integrin induced thromboxane A2generation in - Adenosine diphosphate (ADP)

  2013cites this paper
• thrombin-induced platelet cytoskeletal reorganization IQGAP2 functions as a GTP-dependent effector protein in

  2013cites this paper
• protease-activated receptor-mediated Akt phosphorylation in platelets Relative contribution of G-protein-coupled pathways to

  2012cites this paper
• Combined Blockade of ADP Receptors and PI3-Kinase p110β Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation

  2012cites this paper
• P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

  2012cites this paper
• The Effects of Vanilloid-Like Agents on Platelet Aggregation

  2011cites this paper
• Docking-based virtual screening of potential human P2Y12 receptor antagonists.

  2011cites this paper
• Ser352 and Ser354 in the carboxyl terminus of the human P2Y1 receptor are required for agonist‐promoted phosphorylation and internalization in MDCK cells

  2011cites this paper
• ADP-Rezeptor-Antagonisten: neue Erkenntnisse zur Therapie und Prophylaxe der ischämischen Herzerkrankung

  2011cites this paper
• Microfluidic focal injury models of thrombosis and hemostasis

  2010cites this paper
• Platelet function and HIV: a case–control study

  2010cites this paper
• A structural basis for the inhibition of collagen‐stimulated platelet function by quercetin and structurally related flavonoids

  2010influential citation
• Hemmung der Thrombozytenaggregation mit Prasugrel

  2010cites this paper
• P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.

  2010cites this paper
• Imaging methods for haemostasis research

  2009cites this paper
• ADP receptor-blocker thienopyridines: chemical structures, mode of action and clinical use. A review.

  2009cites this paper
• Department of Physics, Chemistry and Biology

  2009influential citation
• Étude du rôle régulateur de la lamine B1 dans l’activation plaquettaire : base moléculaire de la thromboprotection chez les patients porteurs d'anticoagulant lupique et d'anti-lamine B1

  2009cites this paper
• Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.

  2009cites this paper
• G protein-coupled receptor signaling: role of PAR2 in breast carcinoma metastasis and regulation of agonist-promoted internalization of P2Y1 receptors

  2009cites this paper
• Regulated expression of active biotinylated G-protein coupled receptors in mammalian cells.

  2008cites this paper
• Acciones de la hormona adrenocorticotropa sobre la agregación plaquetaria y formación de trombo en la zona la lesión vascular

  2008cites this paper
• Die Wirkung von 5'Adenosintriphosphat (ATP) auf humane plasmazytoide dendritische Zellen

  2008cites this paper
• P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.

  2007cites this paper
• Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.

  2007cites this paper
• Insulin-like growth factor-1 regulates platelet activation through PI3-Kα isoform

  2007cites this paper
• CHAPTER 10 – The Platelet P2 Receptors

  2007cites this paper
• Rapid generation of a functional NK-cell compartment.

  2007cites this paper
• Agonist-promoted regulation of the P2Y1 receptor: Quantification of native and recombinant receptors with the novel radioligand [32P]MRS2500

  2007cites this paper
• Insulin-like growth factor-1 regulates platelet activation through PI 3K isoform

  2007cites this paper
• Acquired platelet dysfunction.

  2007cites this paper
• Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.

  2007cites this paper
• Activation of Platelet Function Through G Protein–Coupled Receptors Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation in Murine Models Clinical Aspects of Platelet Inhibitors and Thrombus Formation Platelet Adhesion

  2007cites this paper
• Nucleotide receptor signaling in platelets

  2006cites this paper
• [32P]2‐iodo‐N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors

  2006cites this paper
• G-protein dependent platelet signaling--perspectives for therapy.

  2006cites this paper
• Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets.

  2006cites this paper
• Activation of Platelet Function Through G Protein–Coupled Receptors

  2006cites this paper
• The role of ADP receptors in platelet function.

  2006cites this paper
• Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field.

  2005cites this paper
• Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways.

  2005cites this paper
• The P2 receptors in platelet function.

  2005cites this paper
• The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range

  2005influential citation
• The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.

  2005cites this paper
• The P2 Receptors and Congenital Platelet Function Defects

  2005cites this paper
• Platelet Endothelial Aggregation Receptor 1 (PEAR1), a Novel Epidermal Growth Factor Repeat-containing Transmembrane Receptor, Participates in Platelet Contact-induced Activation*

  2005cites this paper
• Platelets in atherothrombosis: lessons from mouse models

  2005cites this paper
• Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.

  2005cites this paper
• Agonist-induced calcium response in single human platelets assayed in a microfluidic device.

  2005cites this paper
• Platelet Aggregation Testing in Platelet-Rich Plasma

  2005cites this paper
• Thrombopoietin Complements Gi- but Not Gq-dependent Pathways for Integrin αIIbβ3 Activation and Platelet Aggregation*

  2005cites this paper
• The P2 Receptors in Platelet Function

  2005cites this paper
• Cellular distribution and functions of P2 receptor subtypes in different systems.

  2004cites this paper
• A Novel Gαq/11-selective Inhibitor*

  2004cites this paper
• Inherited bleeding disorders: disorders of platelet adhesion and aggregation.

  2004cites this paper
• LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22).

  2004cites this paper
• Use of radiolabeled 2-methylthio-ADP to study P2Y receptors on platelets and cell lines.

  2004cites this paper
• Identification of the active metabolite of ticlopidine from rat in vitro metabolites

  2004cites this paper
• Membrane type‐1 matrix metalloproteinase stimulates tumour cell‐induced platelet aggregation: role of receptor glycoproteins

  2004cites this paper
• Different G protein‐coupled signaling pathways are involved in α granule release from human platelets

  2004cites this paper
• macrophage-derived chemokine ( CCL 22 ) when combined with low levels of ADP , thrombin , epinephrine or LDL oxidized by hypochlorous acid causes irreversible platelet aggregation

  2004cites this paper
• Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae.

  2004cites this paper
• Studies of the G protein beta 3 subunit in human hypertension

  2004cites this paper
• A novel Galphaq/11-selective inhibitor.

  2004cites this paper
• ADP receptor antagonists as antiplatelet therapeutics

  2003cites this paper
• Immunolocalization of P2Y1 and TPalpha receptors in platelets showed a major pool associated with the membranes of alpha -granules and the open canalicular system.

  2003cites this paper
• Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.

  2003cites this paper
• IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization.

  2003cites this paper
• Involvement of P2Y receptors in the differentiation of haematopoietic cells

  2003cites this paper
• Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro

  2003cites this paper
• Immunolocalization of P2Y1 and TPα Receptors in Platelets Showed a Major Pool Associated with the Membranes of α-Granules and the Open Canalicular System

  2003cites this paper
• Concurrent responses elicited by isolated activation of platelet G q -coupled receptors, in vitro : a novel approach for their separation and analysis

  2003cites this paper
• Platelet purinergic receptors.

  2003cites this paper
• Evidence for a role for G (cid:1) i1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced G (cid:1) i1 expression and defective G i signaling in the platelets of a patient with a chronic bleeding disorder

  2003cites this paper
• 2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12.

  2003cites this paper
• PKD: a new protein kinase C-dependent pathway in platelets.

  2003cites this paper
• ADP receptors--targets for developing antithrombotic agents.

  2003cites this paper
• Clopidogrel: Interactions with the P2Y12 Receptor and Clinical Relevance

  2003cites this paper
• Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host Defense

  2003cites this paper
• Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP

  2003influential citation
• Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin.

  2003cites this paper
• Attenuation of the P2Y receptor‐mediated control of neuronal Ca2+ channels in PC12 cells by antithrombotic drugs

  2003cites this paper
• Dynamic regulation of microtubule coils in ADP-induced platelet shape change by p160ROCK (Rho-kinase)

  2003cites this paper
• Molecular and biochemical evidence for the presence of Type III adenylyl cyclase in human platelets

  2003cites this paper
• Inherited platelet‐based bleeding disorders

  2003cites this paper
• P2 purinergic receptor-coupled signaling in the rabbit ciliary body epithelium.

  2002cites this paper
• Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial Cells*

  2002cites this paper